$CLGN

CollPlant: Ami Sagy's stake falls to about 5.7%

CollPlant reports Ami Sagy's ownership stake decreased to 5.7% due to new share issuances. Sagy confirms no recent transactions. The calculation is based on 2,866,715 outstanding shares post-reverse split, and he may now report under Rule 13d-1(c).

Original reporting
Published Oct 8, 2026, 2:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 5:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CLGN
Neutral
medium confidence
Mentioned
$CLGN
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CLGNNeutralLow
01

Why it matters

For traders, the key takeaway is whether the change reflects actual selling or is primarily dilution and reverse-split accounting. The article explicitly attributes the percentage drop to share issuances and split-adjusted share counts.

02

Market read

This is a shareholder reporting update with limited direct trading catalyst, unless investors treat it as a signal about dilution or governance.

03

What to watch

The reverse split and the denominator (shares outstanding as of Sept. 30, 2026) can mechanically change reported percentages, so the economic signal may be weaker than the headline implies.

Relevance 4/10Novelty 4/10Timing: latest ownership amendment disclosure, published today

Background

The article summarizes a Schedule 13D/13G-style amendment: Ami Sagy’s beneficial ownership percentage decreased to about 5.7% after CollPlant issued shares, with Sagy stating no transactions since the prior amendment.

Company-level read

Ticker impact

$CLGNNeutralMedium confidence
Context

CollPlant reports Ami Sagy’s beneficial ownership fell to about 5.7%, mainly due to share issuances and a 1-for-10 reverse split.

Expected impact

Likely limited near-term impact, with traders focusing on whether the change reflects dilution from issuances rather than selling.

Evidence & confidence

The article attributes the lower percentage to issuer share issuances and reverse-split share count mechanics, while Sagy states no acquisitions or dispositions since the prior amendment.

Market effects

Minimal, as this is a single-company ownership percentage mechanics update rather than a sector catalyst.

Minimal, no regional macro or cross-border transaction is described.

Low, the news is specific to CollPlant’s shareholder reporting.

Counterpoint

Even if Sagy claims no trades, the reduced reported percentage could still be interpreted by some investors as dilution risk, which may weigh on sentiment.

Key entities

  • CollPlant Biotechnologies Ltd.

    Issuer reporting the beneficial ownership update for Ami Sagy.

  • Ami Sagy

    Manager of the Sagy Group, beneficial owner whose reported stake percentage declined to about 5.7%.

Related articles

$CLGNHighAI 8/10

CollPlant Is Acquiring LightSolver- Enters Supercomputing And Photonic Computing Markets

CollPlant (CLGN) is acquiring LightSolver, a developer of photonic computing technology. LightSolver's Laser Processing Unit (LPU) aims to address computational speed and energy challenges. The deal includes upfront shares, warrants, and milestone-based payments. LightSolver is working with partners like Boeing (BA) to validate its technology, targeting commercial availability by 2028.

$CLGNHighAI 8/10

COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS

CollPlant (Nasdaq: CLGN) is acquiring LightSolver, a company developing photonic computing technology. LightSolver's Laser Processing Unit (LPU) aims to address speed and energy limitations of semiconductor-based computing. The acquisition includes equity and milestone-based warrants. LightSolver is partnering with Boeing (NYSE: BA) and other global leaders for commercial validation. The deal is expected to close this week.

$CLGNMedAI 9/10

CollPlant Biotechnologies (NASDAQ:CLGN) Issues Earnings Results

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly EPS of -$0.23, slightly above analysts’ -$0.24 consensus, according to Zacks. Revenue was $0.07 million versus an expected $0.46 million. The stock opened at $0.40 and was down 0.7%. MarketBeat data shows a $11.50 consensus target and an average “Hold” rating.